Bengaluru-based Stelis Biopharma, the biotech arm of Strides Pharma Science, has raised USD 195 million by means of Series B and Series C funding, which the corporate will use to repay debt and for common company functions.
Source link
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.